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Abstract
Introduction: Stigma is an important environmental risk factor for a variety of outcomes in schizophrenia. In order to
understand and remediate its effects, research is required to assess how stigma experiences are processed at the level of the
individual. To this end, stereotype awareness (SA) with respect to people with mental illness and their families was explored
in persons with psychotic disorder.
Method: Data from the Dutch Genetic Risk and OUtcome of Psychosis project (GROUP) were analyzed. SA was measured
using scales that assess a respondent’s perception of common opinions about people with a mental illness and their
families.
Results: People with higher level of self-esteem were less aware of stereotypes about patients and families. People with
more severe psychopathology reported more awareness of stereotypes about families, not about patients.
Conclusion: Enhancing psychological resources, by increasing self-esteem and the ability to cope with symptoms, can be
targeted to diminish stereotype threat and improve stigma resilience. Interventions can be tailored to individual differences
to increase their impact. Furthermore, in order to diminish detrimental consequences of negative stereotypes, mental health
professionals, health educators and experts by experience can inform the public about mental illness and stigma.
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Introduction
Mental illness is surrounded by negative stereotypes. Schneider
defined stereotypes as ‘‘qualities perceived to be associated with
particular groups or categories of people’’ [1]. When stereotypes
are related to group characteristics, they can lead to public stigma;
self-stigma may arise when they relate to beliefs about the self [2].
Mental illness related stereotypes center around being (un)respon-
sible, dangerous and dependent, having a poor prognosis and poor
social skills [3] and, at the positive side, being creative [4].
According to Ajtony [5], stereotyping is not inherently wrong; it is
a natural function of the human/cultural mind and is therefore
morally neutral in itself. However, uncritical stereotyping can
result in negative consequences for individuals and society. This
plays a central role in the development, justification, maintenance,
and perpetuation of stigmatization [6], and contributes to
discrimination.
The ‘modified labeling theory’ by Link and colleagues [7]
considered societal conceptions of devaluation-discrimination of
‘‘mental patients’’ as the first step in the labeling process. People
labeled with psychiatric problems who live in a culture where
stereotypes about mental illness prevail may anticipate and
internalize attitudes that reflect devaluation and discrimination
[8]. Once labeled, an individual’s societal conceptions become
relevant to the self, altering the individual’s response (cognitive,
emotional and behavioral) in daily life through self-stigma.
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Corrigan, Watson & Barr [9] defined Link’s process of
perceived discrimination as stereotype awareness (SA): ‘‘the person is
aware of the general negative beliefs about mental illness held by
one’s culture’’ (p.876). This concept can be assessed with the
Devaluation of Consumers Scale and the Devaluation of
Consumers Families Scale (DCS and DCFS) [10].
Stigma vulnerability and stereotype awareness
Anyone - with or without mental health complaints - is biased to
a degree in how feedback is perceived and interpreted. The beliefs
one holds about stereotypes in society, or ‘‘what most people
think’’, may be biased. The extent to which stereotypes are
prevalent in society can be over- or underestimated easily.
Negative schemas and psychopathology may increase this bias.
Overestimation of the presence of stereotypes in society or
attaching more value to them, or to the belief of ‘‘what most
people think’’ may indicate stigma vulnerability. Psychological and
social skills that protect against negative schemas, negative
underlying assumptions or bias in information processing and
perception of stereotypes (or SA) may help an individual to
become more stigma-resilient. Ru¨sch and colleagues [11] state that
identifying vulnerability and resilience factors to stress due to
stigma can help reduce the impact of stigma on persons with
schizophrenia and other diagnoses of mental illness. In this study,
we explore the associations of self-esteem and psychopathology
with the individual’s awareness of stereotypes.
Previous work on SA and self-esteem showed that self-esteem
can be influenced negatively by SA [12]. Furthermore, cognitive
processing, emotional thresholds and behavioral responses that are
related to psychopathology, may further influence stigma suscep-
tibility. Both stereotypes about patients as well as their families
may be relevant to people with psychosis. Therefore, we aimed to
investigate SA about patients as well as SA about their families,
self-esteem and psychopathology in this group.
Methods
Data pertain to second wave measures of the Genetic Risk and
OUtcome of Psychosis (GROUP) study, an ongoing longitudinal
multicenter study in Europe. In selected representative geograph-
ical areas of the Netherlands and (Dutch speaking part of)
Belgium, patients were identified through clinicians working in
regional psychosis departments or academic centers. The patients
presenting consecutively at these services either as outpatients or
inpatients were recruited for the study.
Ethics statement
Persons identified as potentially eligible and deemed capable of
providing informed consent by their clinician were given detailed
explanation of the study procedures and were asked for written
informed consent for detailed assessment and for contacting their
first-degree family members (brothers, sisters, parents). Written
informed consent was also obtained from the next of kin,
caretakers, or guardians of those aged 16–17 years. Before written
informed consent was obtained, persons had the opportunity to
think about and ask questions about participation. They could talk
about the study with an independent physician who was not
involved in the study. All potential participants who declined to
participate or otherwise did not participate were eligible for
treatment (if applicable) and were not disadvantaged in any way in
the case of non-participation. The study protocol was approved by
the Ethical Review Board of the University Medical Centre
Utrecht.
Sample
For the current analyses, we used the subsample of the second
wave of the GROUP Maastricht patients sample (N = 219). This
subsample has add-on scales measuring self-esteem and SA. Data
of patients with at least 70% answers on SA-scales were used.
Inclusion criteria for the Maastricht add-on study were: age range
of 16–50 years (at first wave), clinical diagnosis of psychotic
disorder according to the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM-IV) criteria [13], good
command of the Dutch language and able and willing to give
written informed consent.
Materials
Stereotype awareness was measured using the Devaluation of
Consumers Scale (DCS, 8 items) and the Devaluation of
Consumers Families Scale (DCFS, 7 items) [10]. These scales
assess a respondent’s perception of what most other people believe
about people with a mental illness (DCS) and their families
(DCFS). We use two scales because they assess slightly different
domains. All items are rated on a 4-point Likert Scale: strongly
disagree ( = 1), disagree, agree, strongly agree ( = 4). In the
statistical analyses, mean scores of the scales were used as
outcomes (overall scores). The higher the score on the DCS or
DCFS, the more the person is aware of the general negative beliefs
about mental illness held by one’s culture.
Self-esteem was measured using the 10-item Rosenberg Self-
Esteem scale (RSES) [14]. Items are rated on a 4-point Likert
Scale: strongly disagree ( = 0), disagree, agree, strongly agree ( = 3).
We used the individual’s mean item score for analyses. A higher
mean score indicates higher self-esteem.
Psychopathology was measured with an extended version of the
Brief Psychiatric Rating Scale (28-item BPRS) [15–17]. Informa-
tion on both frequency and severity of symptoms in the two weeks
before the interview was used for scoring. Items are rated on a 7-
point ordinal scale. Analyses used the individual’s mean score of all
28 items.
Statistical analysis
Linear regression analysis was conducted with scores on DCS
and DCFS respectively for the assessment of stereotype awareness
as dependent variables and as independent variables, the RSES as
a measure of self-esteem (in model 1), to which was added BPRS
severity in order to assess associations with psychopathology
(model 2). Gender, age, illness duration and ethnicity were added
as a priori confounders in all analyses. Statistical analysis was
carried out using STATA 11.2 [18].
Results
186 patients filled in more than 70% of items in the DCS, and
184 did so for the DCFS. Of the 186 patients, 129 were men
(69%). Mean age was 29.8 years (range 18–53). Most patients were
diagnosed with psychosis spectrum disorder (98%). Mean duration
of illness was 7.7 years (range 2.1–29.1). 89% was of white ethnic
group, 8% of mixed ethnic group, 1% of Moroccan ethnicity, 1%
of Surinamese ethnicity, and 1% of other ethnic group. BPRS
overall score was 1.5 (range 1–3.2), RSES overall score was 2.0
(0.5–3.0). On the devaluation scales, mean overall scores were 2.6
(1–4) for DCS and 2.2 (1–3.7) for DCFS. The correlation between
DCS and DCFS overall scores was 0.56. The correlation between
RSES score and BPRS score was 0.36.
Stereotype Awareness and Self-Esteem
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Stereotype awareness
Cronbach’s alphas of the DCS and DCFS were respectively
0.83 and 0.86, indicating good reliability. A principal component
analysis (PCA) with oblique rotation (oblimin) was conducted to
explore associations in the item set. We identified factors with
eigenvalues larger or equivalent to 0.9. This analysis revealed one
factor for DCS and two factors for DCFS. Eigenvalues of these
factors were 3.84 for DCS and 3.81 and 0.94 for DCFS.
Studying the extent to which patients agreed and disagreed with
statements, the mean percentage of agreement with the DCS-
items was 58%, ranging from 39% for the item ‘‘Most people feel
that having a mental illness is worse than being addicted to drugs’’
to 71% for the item ‘‘Most people think less of a person who has
been a patient in a mental hospital’’ (Table 1). On the DCFS, most
answers indicated disagreement with the statements. The mean
percentage of agreement was 31% ranging from 26% for both of the
items ‘‘Most people in my community would rather not be friends
with families that have a relative who is mentally ill living with
them’’ and ‘‘Most people do blame parents for the mental illness of
their children’’ to 41% for the item ‘‘Most people would not treat
families with a member who is mentally ill in the same way they
treat other families’’ (Table 2).
Self-esteem
The Cronbach’s alpha of the RSES was 0.89 indicating good
reliability. Almost all participants (98%) agreed with the statement
‘‘I feel that I have a number of good qualities’’. On the other hand,
almost half of participants expressed (strong) agreement on the
items ‘‘I wish I could have more respect for myself’’ and ‘‘I
certainly feel useless at times’’.
Linear regression analysis
Results of linear regression analysis showed that in all models,
self-esteem was significantly associated with SA (beta = 20.37,
p7,0.001 in model 2 for DCS and beta = 20.32 in model 2
DCFS). More self-esteem was associated with less SA. Age was
significantly associated with DCS-score (beta = 0.17, p,0.001 in
model 2 DCS). Psychopathology was significantly associated with
DCFS-score (beta = 0.21, p = 0.009 in model 2), but not with
DCS-score. In both models of DCS and DCFS there were no
significant associations between SA and 1) gender, 2) illness
duration, or 3) ethnicity. The explained variance, R˙, ranged from
0.18 (model 1 DCFS) to 0.22 (model 2 DCS), indicating that 18 to
22% of variance in SA was explained by the independent variables
(Table 3).
Discussion
This is, to our knowledge, the first study that shows an
association between stereotype awareness about patients (DCS)
and their families (DCFS) and self-esteem in people with psychotic
disorder. Results show that decreased self-esteem is associated with
increased awareness of stereotypes of patients and their family
members. Furthermore, (severity of) psychopathology is associated
with stereotypes about family members of patients with mental
illness. This reflects that not only patients but also their families
can be the subject of stereotyping and stigmatization, while the
awareness of stereotypes concerning families is associated with
psychopathology. A non-significant association between SA and
severity of psychopathology in the same direction was found in SA
concerning patients.
Being aware of stereotypes held by the public (‘‘most people’’ in
society) with respect to patients’ families, may also be a source of
distress. It may be an indicator of courtesy stigma [19]; the process
of being stigmatized by virtue of association with a stigmatized
individual [20]. When people with mental illness not only perceive
stereotypes about patients but also about families, stigma
experiences may be even more pervasive for the individual.
However, in the present study, patients disagreed (disagree/
strongly disagree) with most of the statements on the DCFS,
indicating that they did not perceive stereotypes about families of
people with mental illness to be held by ‘‘most people’’ in society.
Most participants perceived less stereotypes about family members
of people with mental illness, than stereotypes about patients.
Patients agreed the most with item 4 (‘‘Most people look down
on someone who once was a patients in a mental hospital’’) and 6
(‘‘Most people think less of a person who has been a patient in a
mental hospital’’) of the DCS. According to Struening and
colleagues [10] these items indicate a judgmental reaction to
consumers who have experienced hospitalization for mental
illness, ascribing them a lower status position. These responses
are considered put-downs or expressions of rejection or criticism
[10].
The study showed that higher self-esteem was associated with
less SA. Positive self-esteem is not only seen as a basic feature of






1 Most people would not accept a person who once had a serious mental illness as a close
friend
58.82 41.18
2 Most people think that a person with a serious mental illness is dangerous and unpredictable 41.18 58.82
3 Most people feel that having a mental illness is worse than being addicted to drugs 60.75 39.25
4 Most people look down on someone who once was a patient in a mental hospital 33.33 66.67
5 Most employers will not hire a person who once had a serious mental illness if he or she is
qualified for the job
33.87 66.13
6 Most people think less of a person who has been a patient in a mental hospital 29.03 70.97
7 Most people feel that entering psychiatric treatment is a sign of personal failure 45.16 54.84
8 Most young women would not marry a man who has been treated for a serious mental
disorder
37.63 62.37
Mean percentage of participants 42.5 57.5
doi:10.1371/journal.pone.0088586.t001
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mental health, but also as a protective factor that contributes to
better mental health and positive social behavior through its role
as a buffer against the impact of negative cognitions, emotions and
dysfunctional behavioral responses. Self-esteem represents a
motivational force that influences perceptions and coping. In the
context of negative messages and stressors, positive self-esteem can
have various protective functions [21]. Protective factors interact
with risk to modify its effects in a positive direction [22].
In a model by Watson and coworkers [23], SA is viewed as one
of the components in the process of self-stigma. Other components
are stereotype agreement - endorsing the same stereotypes
perceived to be common in the public - and self-concurrence -
when people believe that culturally internalized beliefs in fact
apply to them [9]. In the present study, high self-esteem is viewed
as a protective factor leading to resilience, while low self-esteem
may be a vulnerability factor for the experience of stigma. Of
course, no causal attributions are possible given the cross-sectional
nature of the data.
Brohan and colleagues [24] found that 42% of people with
schizophrenia or other psychotic disorders experienced self-stigma
in moderate to high levels. Dealing with SA may be a useful way to
diminish self-stigma experiences of the individual. While SA can
be viewed as an indicator of public stigma, people may over- or
underestimate the stereotypes in the public.
A sense of self-worth and a belief that one can control one’s
destiny and life events, actual power, and righteous anger and
community activism are important elements of empowerment
[25]. Rogers and colleagues [25] indicate that programs aimed at
promoting empowerment must focus on, for example, increasing
self-esteem and self-efficacy, decreasing feelings of powerlessness,
and increasing feelings of power. Stigma resilience and empow-
erment may be promoted in therapeutic and/or educational
programs, in which experts by experience can play an important
role. However, functional strategies to cope with stigma have to be
applied in stigmatizing situations in everyday life. The social
network of the individual is important in this respect. A limited
social network may contribute to the vulnerability to internalize
stigmatizing attitudes and to more strongly perceive devaluation
and discrimination [26]. Furthermore, individual as well as
situational characteristics are important in the experience of
stigma: The response to stigma, of an individual with mental
illness, may consist of diminished self-esteem and self-efficacy,
righteous anger and empowerment, or relative indifference,
depending on the parameters of the situation [27]. Corrigan and
Kleinlein [28] state that persons with intact self-esteem will
respond to stigma with indifference or indignation depending on
their identification with the generic group of people with mental
illness. Peterson and Barnes [29] indicate: ‘‘If people with
experience of mental illness are encouraged to empower them-
selves, their self-efficacy and self-esteem will increase, thus
combating self-stigma’’.
Limitations
Data were derived from a cross-sectional survey. Therefore, self-
esteem, psychopathology and SA were measured at the same
moment, precluding conclusions about temporal relationships and
Table 2. Patient’s responses on statements of the DCFS (N= 184).
DCFS
Disagree or Strongly
disagree (%) Agree or Strongly agree (%)
9 Most people in my community would rather not be friends with families that
have a relative who is mentally ill living with them
74.46 25.54
10 Most people believe that parents of children with a mental illness are not as
responsible and caring as other parents
68.48 31.52
11 Most people look down on families that have a member who is mentally ill living
with them
69.02 30.98
12 Most people believe their friends would not visit them as often if a member of
their family were hospitalized for a serious mental illness
68.48 31.52
13 Most people would not treat families with a member who is mentally ill in the
same way they treat other families
59.24 40.76
14 Most people do blame parents for the mental illness of their children 74.46 25.54
15 Most people would rather not visit families that have a member who is mentally
ill
71.20 28.80
Mean percentage of participants 69.3 30.7
doi:10.1371/journal.pone.0088586.t002
Table 3. Results of linear regression analyses on stereotype
awareness (SA).
DCS DCFS
ß p ß p
Model 1 R2 = 0.21 R2 = 0.18
Self-esteem (RSES) 20.41 ,0.001* 20.39 ,0.001*
Gender 0.05 0.481 0.05 0.483
Age 0.16 0.039* 0.13 0.103
Illness duration 20.03 0.701 20.15 0.064
Ethnicity 20.01 0.934 20.03 0.660
Model 2 R2 = 0.22 R2 = 0.21
Self-esteem (RSES) 20.37 ,0.001* 20.32 ,0.001*
Psychopathology
(BPRS)
0.12 0.133 0.21 0.009*
Gender 0.07 0.324 0.11 0.145
Age 0.17 0.029* 0.13 0.086
Illness duration 20.03 0.738 20.13 0.088
Ethnicity 20.02 0.763 20.06 0.413
doi:10.1371/journal.pone.0088586.t003
Stereotype Awareness and Self-Esteem
PLOS ONE | www.plosone.org 4 February 2014 | Volume 9 | Issue 2 | e88586
causality. The results may be influenced by the fact that most
participants (69%) were male and participants reported relatively
low levels of psychopathology (BPRS) in the two weeks before
measurement. Moreover, people were diagnosed with a psychosis
spectrum disorder, which limits our findings to this (broad) group
of individuals. Also, perception of the respondent of ‘‘most
people’s’’ beliefs may be influenced by, for example, alterations in
social cognition such as theory of mind.
Practical implications
Self-esteem and SA may be usefully targeted in anti-stigma
interventions. This strategy may be of particular interest for people
with early symptoms of psychosis. Targeted interventions at this
stage may alter illness outcomes. Perceived stereotyping may
exacerbate early psychopathology in the case of incipient illness, or
increase the probability of relapse in case of established illness, for
instance, by inducing a vicious circle of self-blame, attributing
negative feedback to the self or by increasing stigma consciousness
[30]. Thus, in the phase of early intervention, one of the factors
that may prevent transition to more severe psychopathology is to
increase resilience in subjects with a high level of awareness of
stereotypes. Interventions can help people to deal with stigma, to
increase self-esteem, and to become more stigma-resilient [30].
Future research can inform us on SA, about people with mental
illness and their families, in people with or without other mental
health problems or diagnoses. It may also further inform us on
associations with for example self-esteem and other protective
factors, as well as psychopathology. Research on gender and
stigma-related factors [31,32] can be elaborated to customize
gender-specific interventions. Gender is a source of stereotyping in
itself. Therefore, research on its direct and indirect effects on
stigmatization in people with mental illness is required.
The consequences of stereotype threat [33] may be worse than
SA, for example by increasing stress and interfering with daily life
functioning. In future studies, it is important to include situational
characteristics that can bring about stereotype threat in the flow of
daily life, measured, for example, with the Experience Sampling
Method [34–36].
Conclusion
Enhancing psychological resources, focusing on self-esteem and
the ability to cope with symptoms, may be relevant targets to
increase stigma resilience and empowerment. A higher level of
self-esteem may be a protective factor, and coping with symptoms
may reduce the consequences of stigma experience. SA may
precede or co-occur with self-stigma and can be targeted in
conjunction with other aims of treatment. Interventions can be
tailored to individual differences to increase their effect. In tandem
with the individual approach in patients, the public should be
informed about mental illness and stigma, including the negative
consequences of uncritical stereotyping.
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